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Cocaine produces its psychoactive and addictive effects primarily by acting on the brain’s
limbic system, a set of interconnected regions that regulate pleasure and motivation. An
initial, short-term effect—a buildup of the neurochemical dopamine—gives rise to eupho-
ria and a desire to take the drug again. Researchers are seeking to understand how
cocaine’s many longer term effects produce addiction’s persistent cravings and risk of
relapse. In the author’s laboratory, work has focused on buildup of the genetic transcription
factor ΔFosB. Levels of  ΔFosB in the limbic system correlate with addiction-like behaviors
in mice and may precipitate very long-lasting changes to nerve cell structure. Further pur-
suit of this and similar leads are first steps toward a complete understanding of the transi-
tion from cocaine abuse to addiction—and, ultimately, more effective treatments for those
who are addicted.
N
The Neurobiology of Cocaine Addiction
S
ome 20 years ago, scientists identified the specific brain mechanisms that
underlie the cocaine high. Since then, neurobiologists have focused on the
followup questions:  What does chronic cocaine abuse do to the brain to cause
addiction? In clinical terms, how does repeated cocaine exposure make indi-
viduals compulsively continue to take the drug even when they know it may cost
them their jobs, possessions, loved ones, freedom, and even their lives? Why do
people with every reason and intention to quit for good find it so hard to get
away from the drug, and why do they remain vulnerable to relapse after years of
abstinence?
We do not yet have complete answers to these questions, but we have learned
a great deal. We now know that cocaine affects brain cells in a variety of ways.
Some of its effects revert quickly to normal. Others persist for weeks after the
drug leaves the brain. With repeated exposure to cocaine, these short- and 
intermediate-term effects cumulatively give rise to further effects that last for
months or years and may be irreversible.
This article presents in broad outline the emerging picture of the neuro-
biology of cocaine addiction. It begins with a brief review of cocaine’s immedi-
ate effects on brain function, then focuses on two more recently discovered types
of effects: alterations in genetic activity that last for weeks, and alterations 
of nerve cell structure that last for months and possibly much longer. A protein
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called ΔFosB, currently under study by the author,
provides an example—we suspect an important one—
of how changes in gene activity can promote struc-
tural changes during the progression from abuse to
addiction. Finally, the article discusses how investi-
gations into the neurobiology of cocaine abuse are
providing clues to cocaine vulnerability and the clin-
ical implications of that research.
COCAINE’S INITIAL EFFECT: DOPAMINE
BUILDUP
Snorted, smoked, or injected, cocaine rapidly enters
the bloodstream and penetrates the brain. The drug
achieves its main immediate psychological effect—
the high—by causing a buildup of the neurochemi-
cal dopamine.
Dopamine acts as a pacesetter for many nerve
cells throughout the brain. At every moment of our
lives, dopamine is responsible for keeping those cells
operating at the appropriate levels of activity to accom-
plish our needs and aims. Whenever we need to mobi-
lize our muscles or mind to work harder or faster,
dopamine drives some of the involved brain cells to
step up to the challenge.
Dopamine originates in a set of brain cells, called
dopaminergic (dopamine-making) cells, that manu-
facture dopamine molecules and launch them into
their surroundings. Some of the free-floating dopamine
molecules latch onto receptor proteins on neighbor-
ing (receiving) cells. Once attached, the dopamine
stimulates the receptors to alter electrical impulses
in the receiving cells and thereby alter the cells’
function.
The more dopamine molecules come into con-
tact with receptors, the more the electrical properties
of the receiving cells are altered. To keep the receiv-
ing cells in each brain region functioning at appro-
priate intensities for current demands—neither too
high nor too low—the dopaminergic cells continu-
ally increase and decrease the number of dopamine
molecules they launch. They further regulate the
amount of dopamine available to stimulate the recep-
tors by pulling some previously released dopamine
molecules back into themselves.
Cocaine interferes with this latter control mech-
anism:  It ties up the dopamine transporter, a protein
that the dopaminergic cells use to retrieve dopamine
molecules from their surroundings. As a result, with
cocaine on board, dopamine molecules that other-
wise would be picked up remain in action. Dopamine
builds up and overactivates the receiving cells.
Although cocaine also inhibits the transporters
for other neurotransmitter chemicals (norepineph-
rine and serotonin), its actions on the dopamine sys-
tem are generally thought to be most important.  To
understand the powerful nature of cocaine’s actions,
it is helpful to realize that dopamine pathways in the
brain are very old in evolutionary terms. Early rudi-
ments are found in worms and flies, which take us
back 2 billion years in evolution. Thus, cocaine alters
a neural circuit in the brain that is of fundamental
importance to survival. Such alterations affect the
individual in profound ways that scientists are still
trying to understand.
COCAINE, DOPAMINE, AND THE LIMBIC
SYSTEM
Cocaine produces dopamine buildup wherever the
brain has dopamine transporters. However, its ability
to produce pleasure and euphoria, loss of control, and
compulsive responses to drug-related cues can all be
traced to its impact on the set of interconnected regions
in the front part of the brain that make up the lim-
bic system (Hyman and Malenka, 2001; Kalivas and
McFarland, 2003; Koob, Sanna, and Bloom, 1998;
Nestler, 2001). Dopamine-responsive cells are highly
concentrated in this system, which controls emotional
responses and links them with memories.
One particular part of the limbic system, the
nucleus accumbens (NAc), seems to be the most impor-
tant site of the cocaine high. When stimulated by
dopamine, cells in the NAc produce feelings of pleas-
ure and satisfaction. The natural function of this
response is to help keep us focused on activities that
promote the basic biological goals of survival and
reproduction. When a thirsty person drinks or some-
one has an orgasm, for example, dopaminergic cells
flood the NAc with dopamine molecules. The receiv-
ing cells’ response makes us feel good and want to
repeat the activity and reexperience that pleasure.
By artificially causing a buildup of dopamine in
the NAc, as described above, cocaine yields enor-
mously powerful feelings of pleasure. The amount of
dopamine connecting to receptors in the NAc after a
dose of cocaine can exceed the amounts associated
with natural activities, producing pleasure greater
than that which follows thirst-quenching or sex. In
fact, some laboratory animals, if given a choice, will
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ignore food and keep taking cocaine until they starve.
The limbic system also includes important mem-
ory centers, located in regions called the hippocam-
pus and amygdala. These memory centers help us
remember what we did that led to the pleasures asso-
ciated with dopamine release in the NAc—for exam-
ple, where we found water and how we attracted a
mate. When someone experiences a cocaine high,
these regions imprint memories of the intense plea-
sure as well as the people, places, and things associ-
ated with the drug. From then on, returning to a place
where one has taken cocaine or merely seeing images
of cocaine-related paraphernalia triggers emotionally
loaded memories and desire to repeat the experience.
Scientists believe that repeated cocaine exposure, with
its associated dopamine jolts, alters these cells in ways
that eventually convert conscious memory and desire
into a near-compulsion to respond to cues by seek-
ing and taking the drug.
A third limbic region, the frontal cortex, is where
the brain integrates information and weighs differ-
ent courses of action. The frontal cortex acts as a brake
on the other regions of the limbic system when we
decide to forgo a pleasure in order to avoid its nega-
tive consequences. Activity here can help a nonad-
dicted person heed the disastrous prognosis of con-
tinued cocaine abuse and suppress drug-taking urges
emanating from the NAc, hippocampus, and amyg-
dala. Once someone becomes addicted, however, the
frontal cortex becomes impaired and less likely to pre-
vail over the urges (Nestler and Malenka, 2004; Volkow,
Fowler, and Wang, 2003).
COCAINE’S INTERMEDIATE-TERM
EFFECTS: CHANGES IN GENE 
EXPRESSION 
Cocaine causes many types of intermediate-term alter-
ations in brain cell functioning. For example, expo-
sure to the drug can alter the amounts of dopamine
transporters or dopamine receptors present on the
surface of nerve cells. The changes involving genes,
however, are particularly intriguing. They occur in
the limbic system, the primary site for cocaine effects,
and are sufficiently fundamental and long-lasting
to contribute significantly to the transition from drug
abuse to addiction.
Genes and Gene Expression
Genes determine the shape and function of every cell.
Every individual is born with a unique combina-
tion of roughly 30,000 genes. Every cell in the body
contains all 30,000. One cell differs from another—
a liver cell looks and acts differently from a brain cell,
for example—because, in each, certain genes are turned
on, while others are turned off.
The popular notion that our genes never change
is incorrect. It is true that the fundamental pattern of
gene activation that gives each of our cells its essen-
tial properties is fixed once and for all during devel-
opment. For example, once a cell develops into a liver
cell, it remains a liver cell for life and cannot be
converted into a brain cell. However, every cell retains
the capacity to change the level of activity (expres-
sion) of a portion of its genes in response to the demands
we place upon it. An example is weightlifting: Muscle
cells respond to repeated exercise by increasing the
expression of certain genes, leading to growth and
strengthening of the individual cells and, collectively,
of the entire muscle. So it is with brain cells: As we
use them, they respond with changes in gene expres-
sion that, overall, increase their capacity to meet the
demands we make upon them. For example, our brains
register and store memories by altering gene expres-
sion in cells in the hippocampus and amygdala.
Cocaine affects the expression of numerous genes
within the NAc, including some that influence the
important neurotransmitter chemical glutamate and
the brain’s natural opioid-like compounds produced
by the body (Kalivas and McFarland, 2003; Nestler,
2001). In the author’s University of Texas laboratory,
investigators have been studying cocaine’s effect on one
particular genetic component, a protein called ΔFosB. 
ΔFosB
Like dopamine, ΔFosB is a pace-setting chemical.
However, instead of leaving the cell that produces it
and stimulating neighboring cells as dopamine does,
ΔFosB remains in its original cell and stimulates cer-
tain genes. Chemicals that act this way are called
genetic transcription factors. While cocaine affects
several transcription factors, its effects on ΔFosB
are the most long-lasting.
ΔFosB is naturally present in small quantities in
the cells of the NAc, but chronic cocaine exposure causes
it to accumulate to high levels (Nestler, Barrot, and
Self, 2001). Researchers believe ΔFosB may constitute
an important molecular “switch” in the transition from
drug abuse to addiction, mainly for three reasons:
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• Once created, a molecule of ΔFosB lasts for 6 to 8
weeks before breaking apart chemically (Nestler,
Barrot, and Self, 2001). Therefore, each new episode
of cocaine abuse exacerbates the buildup of ΔFosB
that has accumulated from all previous episodes
during roughly 2 months. If someone is abusing
cocaine daily, the levels of  ΔFosB will be extremely
elevated all the time.
• Mice with elevated ΔFosB exhibit a set of behaviors
that correspond to human addictive behaviors, while
mice with normal levels do not. Conversely, block-
ing the buildup of ΔFosB in mice during 
a regimen of cocaine exposure reduces these 
behaviors.
• ΔFosB plays a role in the genetic machinery that
determines very basic properties of a cell, includ-
ing very long-term or permanent ones such as its
structure and interface with other cells.
Experimental Results With ΔFosB
The author’s research team hypothesized that increas-
ing ΔFosB levels might promote addictive behav-
iors independently of cocaine’s other effects in the
brain. To investigate this idea, we needed to find a
way to control levels of ΔFosB in animals inde-
pendently of cocaine exposure. Molecular biology
gave us the tools to accomplish this. We bred a strain
of mice that are genetically normal with one key dif-
ference: We can turn production of ΔFosB within the
mouse NAc on and off, at will, by giving or with-
holding a chemical that is completely inert in normal
animals.
We tested the animals’ response to cocaine while
varying their ΔFosB levels. When we elevated levels
of ΔFosB in the NAc, the mice exhibited behaviors
that are considered reliable indicators that exposing
people to the same conditions would cause addiction:
Mice with 
elevated ΔFosB
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(Brain inset) Cocaine causes euphoria in the short term and addiction in the long term via its effects on the brain’s limbic system, which con-
sists of numerous regions, including the ventral tegmental area (VTA) and nucleus accumbens (NAc), centers for pleasure and feelings of
reward; the amygdala and hippocampus, centers for memory; and the frontal cortex, a center for weighing options and restraint.
(Main panel) Cocaine causes the neurotransmitter dopamine to build up at the interface between VTA cells and NAc cells, triggering pleasura-
ble feelings and NAc cellular activities that sensitize the brain to future exposures to the drug. Among the activities are increased production
of genetic transcription factors, including ΔFosB; altered gene activity; altered production of potentially many proteins; and sprouting of new
dendrites and dendritic spines.
(Graph inset) The time courses of cocaine-induced buildup of ΔFosB and cocaine-related structural changes (dendrite sprouting) suggest
that these neurobiological effects may underlie some of the drug’s short-term, medium-term, and long-term behavioral effects.
FROM THE RUSH TO THE ADDICTION, COCAINE'S EFFECTS IN THE BRAIN
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They showed more sensitivity to the drug (responded
to doses one-third those required to produce a response
in normal animals), self-administered more drug, and
displayed greater drive (or craving) for cocaine (they
worked two to three times as hard to get the drug)
(McClung et al., 2004; Nestler, Barrot, and Self, 2001).
Conversely, when we blocked the activity of ΔFosB,
we saw the opposite effects, an overall blunting of the
animals’ response to the drug. These results suggest
that cocaine’s buildup of ΔFosB is both necessary and
sufficient for some of the drug’s behavioral effects
and, in particular, its ability to increase drug craving
and drug taking (Nestler, 2001).
Further Clues About ΔFosB’s Significance
The NAc is the only brain region where ΔFosB is
found in normal animals. However, chronic admin-
istration of cocaine has recently been shown to increase
ΔFosB in several additional brain regions, such as the
frontal cortex and amygdala (McClung et al., 2004).
The accumulations of ΔFosB are much smaller in
these regions than those that cocaine causes in the
NAc, and their behavioral consequences are still
unknown. It is tempting to speculate, though, that
the presence of ΔFosB in the frontal cortex may con-
tribute to the loss of frontal cortex control over cocaine
urges that is seen in addiction. Although we do not
yet have direct evidence of this possibility, it repre-
sents an additional mechanism by which ΔFosB may
contribute to a state of addiction.
Scientists currently are working to identify which
specific genes ΔFosB stimulates to produce its effects.
Comparisons of genes expressed in NAc nerve cells
in mice that make ΔFosB versus mice that lack the
transcription factor have revealed more than a hun-
dred ΔFosB-mediated changes in gene expression
(McClung and Nestler, 2003). This work has also
indicated that ΔFosB causes more than 25 percent of
all chronic cocaine-induced changes in gene expres-
sion in the NAc—a finding that highlights the dom-
inant role of this transcription factor in mediating
cocaine’s genetic effects in the brain. One of the genes
stimulated by ΔFosB is an enzyme, cyclin-dependent
kinase-5 (CDK5), which promotes nerve cell growth.
This finding has shed new light on mechanisms under-
lying cocaine’s very long-lasting effects on the brain
(Nestler, 2001).
COCAINE’S LONG-TERM EFFECTS:
CHANGES IN NERVE CELL STRUCTURE
With its 2-month lifespan, ΔFosB does not last
long enough to explain why former cocaine abusers
continue to experience cravings and relapse after
months and years of abstinence. The extreme per-
sistence of those features of addiction indicates that
cocaine must cause some equally long-lasting neuro-
biological effects. Scientists have identified one poten-
tially key type of cocaine-related change that appears
to last for many months after the last cocaine expo-
sure, and perhaps longer: an alteration in the physi-
cal structure of nerve cells in the NAc. Chronic cocaine
exposure causes these cells to extend and sprout
new offshoots on their dendrites (Nestler, 2001;
Robinson and Berridge, 2001). Dendrites are the
branch-like fibers that grow out from nerve cell bod-
ies and collect incoming signals from other nerve cells.
Just as a bigger antenna picks up more radio waves,
more dendrite branches in the NAc theoretically will
collect a greater volume of nerve signals coming from
other regions—for example, the hippocampus, amyg-
dala, and frontal cortex. This will give those other
regions an enhanced influence over the NAc, which
could drive some of the very long-lived behavioral
changes associated with addiction. For example,
enhanced inputs from the hippocampus and amyg-
dala could be responsible for the intense craving that
occurs when drug-associated memories are stimulated
(e.g., by drug paraphernalia).
While we do not yet know how cocaine triggers
NAc nerve cells to grow and sprout new offshoots,
ΔFosB appears to be involved. Recall that one of
the genes stimulated by ΔFosB is CDK5, a known
regulator of nerve cell growth. When laboratory ani-
mals are treated with a compound that deactivates
CDK5 in the NAc and then are given cocaine, the
nerve cell growth normally associated with expo-
sure to the drug does not occur. 
INDIVIDUAL RISK FOR COCAINE 
ADDICTION
What makes certain individuals particularly vulner-
able to addiction and others relatively resistant?
Extensive epidemiological studies show that roughly
half of a person’s risk for addiction to cocaine or other
drugs is genetic (Goldstein, 2001; Nestler and Malenka,
2004). This degree of heritability exceeds that of many
other conditions that are considered highly heritable,
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such as type 2 (non-insulin-dependent) diabetes,
hypertension, and breast cancer. 
The specific genes that confer risk for cocaine
addiction remain unknown. One possibility is that
at least some of them are the same genes that are
affected by cocaine exposure. For example, variations
in the genes encoding ΔFosB or any of hundreds of
other genes affected by cocaine could conceivably
contribute to the genetic risk for addiction. It is easy
to imagine, by way of illustration, that an individual
with a gene that expresses ΔFosB at high levels might
be more prone to addiction; such a person would be
analogous to the experimental mice that are engi-
neered to produce more ΔFosB and are, consequently,
more addiction prone. It is also possible that other
genes—genes not affected by cocaine exposure—are
responsible. Work is now under way to examine these
alternatives. 
Finding addiction vulnerability genes will enable
us to identify individuals who are at particular risk
for an addictive disorder and target them for educa-
tional and other preventive measures. It will also help
us understand how factors other than genetics con-
tribute to the development of addiction. For exam-
ple, it has long been known that stress can increase
an individual’s risk for addiction, but how stress pro-
duces this effect, and why it does so in some indi-
viduals but not others, remains a mystery.
CLINICAL RAMIFICATIONS
Research to understand the neurobiology of cocaine
addiction is essential because the available treatments
do not work for everyone, and the surest path toward
definitive treatments and even cures, as well as pre-
vention, is through greater appreciation of the under-
lying neurobiological mechanisms (Goldstein, 2001;
O’Brien, 2003). The identification of underlying 
biological mechanisms has been crucial for all major
advances in treatment of other medical disorders, and
there is no reason to think addiction will be any dif-
ferent.
To date, most efforts to develop new medica-
tions for treatment of cocaine addiction have focused
on preventing or suppressing the drug’s acute effects.
Cocaine “vaccines,” for example, are designed to bind
cocaine molecules in the blood with antibodies and
so keep them from getting into the brain. A related
approach seeks to develop a medication that keeps
cocaine from tying up the dopamine transporter with-
out itself interfering with the transporter’s normal
function of dopamine retrieval. Still other approaches
attempt to take advantage of the fact that cocaine’s
acute effects on the brain involve increased activation
of dopamine receptors. NAc nerve cells make five
types of dopamine receptors; drugs that affect the
functioning of one or more of them could, in theory,
produce a palliative effect on cocaine addiction. Efforts
are under way in each of these areas, including clin-
ical trials, but so far no clear breakthrough has been
reported. 
A potential limitation of these approaches is that
they focus on cocaine’s initial actions, not on the long-
lasting changes that are present in the brain once
addiction has been established. A medication aimed
at preventing or reversing such changes might be an
effective approach for treating cocaine addiction.
There are literally hundreds of proteins that could be
targeted in development of such a medication. For
example, ΔFosB, or any of the hundred or so proteins
it regulates, represent possible drug targets. The same
is true for numerous additional molecular changes
that have been implicated in cocaine addiction.
Glutamate receptors and receptors for the brain’s nat-
ural opioid-like substances (e.g., κ opioid receptors)
are two examples.
Effective medications for treating cocaine addic-
tion will eventually be developed, and the best strat-
egy for progress in this area is to target neurobio-
logical mechanisms, such as those described above.
Although the process takes a very long time—it can
take 10 to 20 years to advance from identification of
a disease mechanism to development of a new treat-
ment—this work is in progress and represents the best
hope for those who are addicted.
People often ask: Is it possible to treat a drug
addiction with another drug? Isn’t addiction a 
complex psychological and social phenomenon that
requires psychological and social treatments? The
answer to both questions is “yes.”
Even though psychological and social factors
predominate in the presentation and diagnosis of
addiction, the disease is at its core biological: changes
that a physical substance (drug) causes in vulnerable
body tissue (brain). Today’s treatments do not effec-
tively control the biology of addiction, leaving the
addicted individual with a dramatically altered lim-
bic system. He or she must then work against pow-
erful biological forces to recover from addiction; those
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who succeed often do so only after many attempts,
and many do not succeed.  
While a medication that counters the powerful
biological forces of addiction is essential, it will not
be a “magic bullet.” People in recovery from addic-
tion will always need support and rehabilitation to
rebuild their lives. Presumably, effective psychosocial
treatments for addiction work by causing changes
in the brain, perhaps even some of the same changes
that will be produced by effective medications. While
very little information is currently available on the
neurobiological mechanisms underlying psychosocial
treatments, this is a topic of great interest.
CONCLUSION
In the last two decades, scientists have determined
how cocaine produces intoxication through its initial
effects in the brain’s limbic system, and we are begin-
ning to understand the neurobiological mecha-
nisms underlying the drug’s later developing and longer
lasting effects of craving and relapse vulnerability.
Among the most intriguing of these mechanisms is
elevation of the genetic transcription factor ΔFosB, a
molecule that lasts for approximately 2 months and
theoretically can promote neuron structural changes
that have potentially lifelong persistence. The most
important goal for the next decade is to translate the
knowledge we have already gained, along with any
future advances we make, into better treatments for
addiction.
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